Investors in this round included Sevin Rosen Funds, Aurora Funds, and Trelys Funds. Harris & Harris Group participated as a new investor, contributing $2.5 million.
Metabolon, based in Research Triangle Park, NC, uses metabolomics to discover biomarkers. The company has ongoing biomarker-discovery collaborations with the National Cancer Institute, the Amyotrophic Lateral Sclerosis Association, and the US Centers for Disease Control and Prevention, among others.
The company raised $9 million in Series A funding in October 2004.